Narcolepsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Type (Type 1, Type 2, Others), By Diagnosis (Polysomnogram, Multiple Sleep Latency Test, Others), By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others), By End User (Hospitals, Clinics, Retail Pharmacies, Others), By Region and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationNarcolepsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Type (Type 1, Type 2, Others), By Diagnosis (Polysomnogram, Multiple Sleep Latency Test, Others), By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others), By End User (Hospitals, Clinics, Retail Pharmacies, Others), By Region and Competition
According to Clinical trials. gov,131 studies have been found for narcolepsy drugs. Among them
Growing Prevalence of Narcolepsy
Growing Initiatives by Government Organizations
According to the National Institute of Neurological Disorders and Stroke fact sheet updated in November 2021, narcolepsy affects anywhere between 135,000 and 200,000 people in the United States.
Market Segmentation
The global narcolepsy market can be segmented on the basis of type, diagnosis, treatment, end user, and by region. Based on the type, the market can be segmented into Type 1, Type 2, and Others. Based on diagnosis, the market can be further divided into polysomnograms, multiple sleep latency test, and others. On the basis of the treatment, the market can be further split into stimulants, antidepressants, sodium oxybate, and others. Based on end users, the market can be split into hospitals, clinics, retail pharmacies, and others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global narcolepsy market on account of the increasing incidence of sleep disorders in the country.
Recent Development
- In December 2021, Ligand Pharmaceuticals, Inc. announced the expansionof its existing collaboration and license agreement between its subsidiary,Icagen and GSK. This expansion will leverage Icagen’s ion-channel-baseddiscovery technology and unique expertise in small molecule therapeuticstargeting transmembrane proteins. This new agreement builds upon the initialDecember 2020 agreement to identify and develop inhibitors of a specificgenetically-validated molecular target relevant to neurological diseases.
- In January 2020, AdarePharmaceuticals, Inc. and NLS Pharmaceutics Ltd. collaborated to develop mazindolCR product candidates for the treatment of narcolepsy and Attention DeficitHyperactivity Disorder (ADHD).
Market Players
Jazz Pharmaceuticals Plc., BIOPROJET., Arena Pharmaceuticals, Inc.,Graymark Healthcare, Inc. , Mylan N.V. , Teva Pharmaceutical Industries Ltd. , Novartis AG., Shire., Shionogi Inc., Ligand Pharmaceuticals, Inc are some of the leading players operating in the Global
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Type By Diagnosis By Treatment By End User By Region |
| Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
| Country scope | United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE |
| Key companies profiled | Jazz Pharmaceuticals Plc., BIOPROJET., Arena Pharmaceuticals, Inc., Graymark Healthcare, Inc., Mylan N.V. , Teva Pharmaceutical Industries Ltd. , Novartis AG., Shire., Shionogi Inc., Ligand Pharmaceuticals, Inc |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy